350
Participants
Start Date
September 17, 2019
Primary Completion Date
December 31, 2025
Study Completion Date
November 30, 2026
GEN1042
Intravenous
Pembrolizumab
Intravenous
Cisplatin
Intravenous
Carboplatin
Intravenous
5-FU
Intravenous
Gemcitabine
Intravenous
Nab paclitaxel
Intravenous
Pemetrexed
Intravenous
Paclitaxel
Intravenous
University of Pennsylvania, Philadelphia
Fox Chase Cancer Center, Philadelphia
ChristianaCare, Newark
Maryland Oncology Hematology PA, Columbia
Virgina Cancer Specialists, Fairfax
Novant Health Cancer Institute - Forsyth (Medical Oncology), Winston-Salem
Levine Cancer Center, Charlotte
Mount Sinai Comprehensive Cancer Center, Miami Beach
Florida Cancer Affiliates, Ocala
Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria
Sarah Cannon Research Institute, Nashville
Norton Cancer Institute, Louisville
University of Kentucky, Lexington
Hope and Healing Cancer Services, Hinsdale
Washington University School of Medicine, St Louis
Lumi Research, Kingwood
Utah Cancer Specialists, Salt Lake City
Cancer & Blood Specialty Clinic, Los Alamitos
Moores Cancer Center at the UC San Diego Health, San Diego
Kaiser Permanente (KP) Oncology/Hematology, Portland
Adventist Health System/Sunbelt,Inc, Seattle
Medical Oncology Associates, PS, Spokane
Alaska Oncology and Hematology LLC, Anchorage
Yale University Cancer Center, New Haven
Rigshospitalet (Copenhagen University Hospital), Copenhagen
Herlev University Hospital, Herlev
University Hospital of Southern Denmark, Vejle Hospital, Vejle
Centre hospitalier Universitaire de Bordeaux, Bordeaux
Centre Antoine Lacassagne, Nice
Gustave Roussy, Villejuif
ARENSIA Research Clinic at the Research Institute of Clinical Medicine, Tbilisi
Nationales Centrum fr Tumorerkrankungen NCT, Heidelberg
Klinikum der Stadt Ludwigshafen am Rhein gGmbH, Ludwigshafen
Department of Dermatology, University of Mainz, Mainz
Universitätsmedizin Mannheim Dermatologie, Mannheim
Universitaetsklinikum Wuerzburg, Würzburg
Rabin Medical Center, Petah Tikva
Tel Aviv Sourasky Medical Center, Tel Aviv
Azienda Ospedaliera Spedali Civili di Brescia, Brescia
Azienda Ospedaliera S.Croce e Carle Cuneo, Cuneo
Istituto Nazionale dei Tumori, Milan
Istituto Clinico Humanitas, Rozzano
ARENSIA Research Clinic at the Oncology Institute, Chisinau
Chungbuk National University Hospital, Cheongju-si
Jeonbuk National University Hospital, Jeonju
Gachon University Gil Medical Center, Namdong
Korea University Guro Hospital, Seoul
Samsung Medical Center, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Pusan National University Yangsan Hospital, Yangsan
H. Vall d'Hebron, Barcelona
START Barcelona HM Nou Delfos, Barcelona
Hospital Duran i Reynals - ICO L Hospitalet, L'Hospitalet de Llobregat
Hospital Universitario Lucus Augusti, Lugo
Clinica Universidad de Navarra, Madrid
HM CIOCC Hospital Universitario HM Sanchinarro, Madrid
Hospital Clinico San Carlos, Madrid
Hospital General Universitario Gregorio Maran, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Hospital Universitario Ramon y Cajal, Madrid
MD Anderson Cancer Center Madrid, Madrid
START Madrid - Hospital Universitario Fundacion Jimenez Diaz, Madrid
Hospital Universitario Virgen de la Victoria, Málaga
Clinica Universidad de Navarra, Pamplona
Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela
Hospital Virgen del Rocio, Seville
Hospital Clinico Universitario de Valencia, Valencia
Chang Gung Memorial Hospital (CGMH) - Kaohsiung Branch, Kaohsiung City
Kaohsiung Medical University Memorial Hospital, Kaohsiung City
China Medical University Hospital, Taichung
National Cheng Kung University Hospital, Tainan City
Taipei Medical University Hospital, Taipei
Taipei Veterans General Hospital, VGHTPE, Taipei
Chang Gung Memorial Hospital Linkou Branch, Taoyuan District
Royal Marsden NHS Foundation Trust, Sutton
Lead Sponsor
Collaborators (1)
BioNTech SE
INDUSTRY
Genmab
INDUSTRY